Log In / Sign Up

HB 7245

  • Rhode Island House Bill
  • 2022 Regular Session
  • Introduced in House Jan 28, 2022
  • House
  • Senate
  • Governor

AN ACT RELATING TO BUSINESSES AND PROFESSIONS -- THE DRUG COST TRANSPARENCY ACT (Allows drug cost transparency by requiring reports be submitted by drug manufacturers, pharmacy benefit managers and health benefit plan insurers for analysis to the director of the department of business regulation regarding prescription drugs.)

View Latest Bill Text
Sign In to Follow

Abstract

Bill Sponsors (8)

Mia Ackerman

  • Democratic
  • Representative
  • District 45
Primary

Joseph McNamara

  • Democratic
  • Representative
  • District 19
Primary

Katie Kazarian

  • Democratic
  • Representative
  • District 63
Primary

Michelle McGaw

  • Democratic
  • Representative
  • District 71
Primary

David Bennett

  • Democratic
  • Representative
  • District 20
Primary

Blake A. Filippi

  • Republican
Primary

Liana Cassar

  • Democratic
Primary

Brian Kennedy

  • Democratic
  • Representative
  • District 38
Primary

Votes

No votes to display

Actions

Mar 03, 2022

Rhode Island General Assembly

03/03/2022 Committee recommended measure be held for further study

Feb 24, 2022

Rhode Island General Assembly

02/24/2022 Scheduled for hearing and/or consideration (03/03/2022)

Jan 28, 2022

House

01/28/2022 Introduced, referred to House Health & Human Services

Bill Text

Bill Text Versions Format
7245 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Rhode Island General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.